Applied research and product development in the field of biotechnology is central to the core mission of the ICGEB. This is in parallel with the growing international perception that biotechnology can offer practical and sustainable solutions for the diagnosis and treatment of human disease. Two Groups, one in Trieste and one in New Delhi, have multiple interests in the biomedical field and are developing their research in close collaboration with industries in the ICGEB Member States.
Biotherapeutic Products
At ICGEB Trieste, the Biotechnology Development Unit (Skoko) focuses on the development of technologies for the production of biopharmaceuticals, to increase know-how and capabilities of pharmaceutical industries in Member States by transferring lab and pilot scale technologies for the production and quality control of off-patent recombinant proteins.
Computational Biology & Bioinformatics
Bioinformatics is an interdisciplinary research field combining computer science methods and statistical / mathematical modelling to analyse biological measurement data.
Functional Cell Biology
The scientific activity carried out by the group is focused on the systematic use of innovative High Throughput Screening (HTS) based approaches to dissect complex biological processes, both in normal and pathological conditions.
Biomanufacturing
At ICGEB Trieste, Biomanufacturing (Molloy Group) focuses on developing open source tools and technologies for distributed biomanufacturing. Applying protein engineering, DNA assembly and biomanufacturing techniques to diagnostics and industrial sustainability.
Advanced Disease Models
The Sorrentino Group at ICGEB Trieste, studies the fundamental principles that regulate chronic liver diseases progression, with the ultimate goal of translating this knowledge to design innovative disease models, cancer treatments and regenerative medicine therapies.
Regulatory Science
The effective and safe use of biotechnologies requires a broad portfolio of policies, regulations, and processes to support national decision-makers. By applying an integrated, synergistic, and tailored approach, the ICGEB Regulatory Science Group assists countries to create and enhance national capacities in the regulation of biotechnology and its products.
How can you help?
Provide technologies for the development of locally-produced diagnostic kits for HIV, HCV, Dengue and Zika, and to develop novel viral diagnostics.